SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-03-015755
Filing Date
2003-07-01
Accepted
2003-07-01 16:59:15
Documents
2
Period of Report
2003-08-21

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY NOTICE AND PROXY STATEMENT dpre14a.htm PRE 14A 428016
3 GRAPHIC g34059g37e23.jpg GRAPHIC 57542
  Complete submission text file 0001193125-03-015755.txt   487103
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-23272 | Film No.: 03768635
SIC: 2836 Biological Products, (No Diagnostic Substances)